This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Neuraltus Pharmaceuticals, Inc.
Drug Names(s): NP002
Description: NP002 is a small molecule, orally available nicotinic receptor agonist that has been shown in preclinical studies to reduce levodopa-induced dyskinesias (LIDs) without affecting Parkinsonian symptoms.
Pink Sheet FDA Performance Tracker: User Fee Goal Dates
Additional information available to subscribers only: